Please enable JavaScript to continue using this application.

Compare $AZTA vs $PACB | Chartloom

Compare

$AZTA vs $PACB

Azenta Inc · Pacific Biosciences of California Inc

AZTA

Azenta Inc

PACB

Pacific Biosciences of California Inc

Compare $AZTA vs $PACB

Comparing Azenta Inc and Pacific Biosciences of California Inc

AZTAAzenta Inc

PACBPacific Biosciences of California Inc

AZTAAzenta Inc

Market cap

$1.74B

P/E (TTM)

—

Forward P/E (NTM)

66.47x

Forward P/S (NTM)

2.69x

Rev growth (TTM)

1.4%

YTD performance

13.0%

52W performance

17.0%

FCF yield

0.6%

PACBPacific Biosciences of California Inc

Market cap

$724M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

4.11x

Rev growth (TTM)

2.0%

YTD performance

26.6%

52W performance

54.3%

FCF yield

-18.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AZTA

PACB

Detailed metrics comparison

AZTA

Azenta Inc

PACB

Pacific Biosciences of California Inc

Market Cap

AZTA$1.74B

PACB$724M

Enterprise Value

AZTA$1.55B

PACB$1.31B

Price

AZTA$37.72

PACB$2.33

P/E Ratio

AZTAN/A

PACBN/A

P/S Ratio

AZTA2.83x

PACB4.54x

EV/Sales

AZTA2.52x

PACB8.21x

EV/EBITDA

AZTA37.55x

PACB40.33x

P/B Ratio

AZTA1.12x

PACB333.69x

P/FCF Ratio

AZTA175.95x

PACBN/A

EV/FCF

AZTA156.75x

PACB-10.00x

PEG Ratio

AZTAN/A

PACBN/A

Forward P/E (NTM)

AZTA66.47x

PACBN/A

Forward P/S (NTM)

AZTA2.69x

PACB4.11x

Revenue (TTM)

AZTA$614M

PACB$159M

Revenue Growth (YoY)

AZTA1.4%

PACB2.0%

Forward Rev Growth

AZTA5.4%

PACB15.4%

Gross Margin (TTM)

AZTA43.4%

PACB39.2%

Operating Margin (TTM)

AZTA0.0%

PACB0.0%

EBITDA Margin (TTM)

AZTA5.3%

PACB-88.6%

Net Margin (TTM)

AZTA-20.0%

PACB-82.5%

FCF Margin (TTM)

AZTA1.6%

PACB-82.0%

Net Income (TTM)

AZTA$-123M

PACB$-131M

FCF (TTM)

AZTA$10M

PACB$-131M

EPS (TTM)

AZTA-$2.71

PACB-$0.42

ROE (TTM)

AZTA-756.0%

PACB-48845.0%

ROA (TTM)

AZTA-621.0%

PACB-1684.0%

ROIC (TTM)

AZTA-756.0%

PACB-1914.0%

Cash

AZTA$190M

PACB$61M

Debt

AZTA$0

PACB$644M

Net Cash/Debt

AZTA$190M

PACB$-583M

Current Ratio (TTM)

AZTA2.50x

PACB4.92x

Quick Ratio (TTM)

AZTA2.12x

PACB3.90x

Debt/Equity (TTM)

AZTA0.00x

PACB272.23x

Debt/Assets (TTM)

AZTA0.0%

PACB0.0%

Interest Coverage (TTM)

AZTAN/A

PACBN/A

Net Debt/EBITDA (TTM)

AZTA0.00x

PACB0.00x

Beta

AZTA1.51

PACB2.25

52W Performance

AZTA17.0%

PACB54.3%

YTD Performance

AZTA13.0%

PACB26.6%

% from 52W High

AZTA-18.7%

PACB-32.2%

% from 52W Low

AZTA136.8%

PACB117.8%

Asset Turnover (TTM)

AZTA0.31x

PACB0.20x

FCF Yield (TTM)

AZTA0.6%

PACB-18.1%

Earnings Yield (TTM)

AZTA-7.1%

PACB-18.2%

Dividend Yield (TTM)

AZTAN/A

PACBN/A

Rule of 40

AZTA3.0

PACB-80.0

EV/GP/RG

AZTA0.83

PACB1.70

Ticker research

View AZTA research View PACB research

Metric	AZTA Azenta Inc	PACB Pacific Biosciences of California Inc
Market & Valuation
Market Cap	$1.74B	$724M
Enterprise Value	$1.55B	$1.31B
Price	$37.72	$2.33
P/E Ratio	N/A	N/A
P/S Ratio	2.83x	4.54x
EV/Sales	2.52x	8.21x
EV/EBITDA	37.55x	40.33x
P/B Ratio	1.12x	333.69x
P/FCF Ratio	175.95x	N/A
EV/FCF	156.75x	-10.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	66.47x	N/A
Forward P/S (NTM)	2.69x	4.11x
Revenue & Growth
Revenue (TTM)	$614M	$159M
Revenue Growth (YoY)	1.4%	2.0%
Forward Rev Growth	5.4%	15.4%
Profitability
Gross Margin (TTM)	43.4%	39.2%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	5.3%	-88.6%
Net Margin (TTM)	-20.0%	-82.5%
FCF Margin (TTM)	1.6%	-82.0%
Net Income (TTM)	$-123M	$-131M
FCF (TTM)	$10M	$-131M
EPS (TTM)	-$2.71	-$0.42
ROE (TTM)	-756.0%	-48845.0%
ROA (TTM)	-621.0%	-1684.0%
ROIC (TTM)	-756.0%	-1914.0%
Financial Health
Cash	$190M	$61M
Debt	$0	$644M
Net Cash/Debt	$190M	$-583M
Current Ratio (TTM)	2.50x	4.92x
Quick Ratio (TTM)	2.12x	3.90x
Debt/Equity (TTM)	0.00x	272.23x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.51	2.25
52W Performance	17.0%	54.3%
YTD Performance	13.0%	26.6%
% from 52W High	-18.7%	-32.2%
% from 52W Low	136.8%	117.8%
Efficiency & Yields
Asset Turnover (TTM)	0.31x	0.20x
FCF Yield (TTM)	0.6%	-18.1%
Earnings Yield (TTM)	-7.1%	-18.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	3.0	-80.0
EV/GP/RG	0.83	1.70
Ticker research	View AZTA research	View PACB research

Valuation

P/S Ratio

AZTA

2.83x

PACB

4.54x

EV/FCF

PACB

-10.00x

AZTA

156.75x

Growth & revenue

Revenue Growth TTM

PACB

2.0%

AZTA

1.4%

Forward Revenue Growth

PACB

15.4%

AZTA

5.4%

Profitability & performance

Gross Margin

AZTA

43.4%

PACB

39.2%

ROE

AZTA

-756.0%

PACB

-48845.0%

FCF Yield %

AZTA

0.6%

PACB

-18.1%

52-Week Performance

PACB

54.3%

AZTA

17.0%

Detailed metrics comparison

AZTA

Azenta Inc

PACB

Pacific Biosciences of California Inc

Market Cap

AZTA$1.74B

PACB$724M

Enterprise Value

AZTA$1.55B

PACB$1.31B

Price

AZTA$37.72

PACB$2.33

P/E Ratio

AZTAN/A

PACBN/A

P/S Ratio

AZTA2.83x

PACB4.54x

EV/Sales

AZTA2.52x

PACB8.21x

EV/EBITDA

AZTA37.55x

PACB40.33x

P/B Ratio

AZTA1.12x

PACB333.69x

P/FCF Ratio

AZTA175.95x

PACBN/A

EV/FCF

AZTA156.75x

PACB-10.00x

PEG Ratio

AZTAN/A

PACBN/A

Forward P/E (NTM)

AZTA66.47x

PACBN/A

Forward P/S (NTM)

AZTA2.69x

PACB4.11x

Revenue (TTM)

AZTA$614M

PACB$159M

Revenue Growth (YoY)

AZTA1.4%

PACB2.0%

Forward Rev Growth

AZTA5.4%

PACB15.4%

Gross Margin (TTM)

AZTA43.4%

PACB39.2%

Operating Margin (TTM)

AZTA0.0%

PACB0.0%

EBITDA Margin (TTM)

AZTA5.3%

PACB-88.6%

Net Margin (TTM)

AZTA-20.0%

PACB-82.5%

FCF Margin (TTM)

AZTA1.6%

PACB-82.0%

Net Income (TTM)

AZTA$-123M

PACB$-131M

FCF (TTM)

AZTA$10M

PACB$-131M

EPS (TTM)

AZTA-$2.71

PACB-$0.42

ROE (TTM)

AZTA-756.0%

PACB-48845.0%

ROA (TTM)

AZTA-621.0%

PACB-1684.0%

ROIC (TTM)

AZTA-756.0%

PACB-1914.0%

Cash

AZTA$190M

PACB$61M

Debt

AZTA$0

PACB$644M

Net Cash/Debt

AZTA$190M

PACB$-583M

Current Ratio (TTM)

AZTA2.50x

PACB4.92x

Quick Ratio (TTM)

AZTA2.12x

PACB3.90x

Debt/Equity (TTM)

AZTA0.00x

PACB272.23x

Debt/Assets (TTM)

AZTA0.0%

PACB0.0%

Interest Coverage (TTM)

AZTAN/A

PACBN/A

Net Debt/EBITDA (TTM)

AZTA0.00x

PACB0.00x

Beta

AZTA1.51

PACB2.25

52W Performance

AZTA17.0%

PACB54.3%

YTD Performance

AZTA13.0%

PACB26.6%

% from 52W High

AZTA-18.7%

PACB-32.2%

% from 52W Low

AZTA136.8%

PACB117.8%

Asset Turnover (TTM)

AZTA0.31x

PACB0.20x

FCF Yield (TTM)

AZTA0.6%

PACB-18.1%

Earnings Yield (TTM)

AZTA-7.1%

PACB-18.2%

Dividend Yield (TTM)

AZTAN/A

PACBN/A

Rule of 40

AZTA3.0

PACB-80.0

EV/GP/RG

AZTA0.83

PACB1.70

Ticker research

View AZTA research View PACB research

Metric	AZTA Azenta Inc	PACB Pacific Biosciences of California Inc
Market & Valuation
Market Cap	$1.74B	$724M
Enterprise Value	$1.55B	$1.31B
Price	$37.72	$2.33
P/E Ratio	N/A	N/A
P/S Ratio	2.83x	4.54x
EV/Sales	2.52x	8.21x
EV/EBITDA	37.55x	40.33x
P/B Ratio	1.12x	333.69x
P/FCF Ratio	175.95x	N/A
EV/FCF	156.75x	-10.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	66.47x	N/A
Forward P/S (NTM)	2.69x	4.11x
Revenue & Growth
Revenue (TTM)	$614M	$159M
Revenue Growth (YoY)	1.4%	2.0%
Forward Rev Growth	5.4%	15.4%
Profitability
Gross Margin (TTM)	43.4%	39.2%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	5.3%	-88.6%
Net Margin (TTM)	-20.0%	-82.5%
FCF Margin (TTM)	1.6%	-82.0%
Net Income (TTM)	$-123M	$-131M
FCF (TTM)	$10M	$-131M
EPS (TTM)	-$2.71	-$0.42
ROE (TTM)	-756.0%	-48845.0%
ROA (TTM)	-621.0%	-1684.0%
ROIC (TTM)	-756.0%	-1914.0%
Financial Health
Cash	$190M	$61M
Debt	$0	$644M
Net Cash/Debt	$190M	$-583M
Current Ratio (TTM)	2.50x	4.92x
Quick Ratio (TTM)	2.12x	3.90x
Debt/Equity (TTM)	0.00x	272.23x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.51	2.25
52W Performance	17.0%	54.3%
YTD Performance	13.0%	26.6%
% from 52W High	-18.7%	-32.2%
% from 52W Low	136.8%	117.8%
Efficiency & Yields
Asset Turnover (TTM)	0.31x	0.20x
FCF Yield (TTM)	0.6%	-18.1%
Earnings Yield (TTM)	-7.1%	-18.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	3.0	-80.0
EV/GP/RG	0.83	1.70
Ticker research	View AZTA research	View PACB research